FindTrial
Sign In

MTM-H-001 Injection

DRUG2 trials

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing GoBroad Hospital

Conditions

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)IgG4-Related DiseasesLupus Nephritis (LN)Lymphoma, B-Cell, Marginal ZoneLymphoma, FollicularLymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, Mantle-CellMultiple Sclerosis

Unknown Phase

A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies
Not yet recruitingNCT07476378
Cancer Institute and Hospital, Chinese Academy of Medical SciencesChronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Lymphoma, B-Cell, Marginal Zone, Lymphoma, Follicular +3
Start: 2026-03-01End: 2028-06-01Target: 69Updated: 2026-03-17
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
Not yet recruitingNCT07593911
Beijing GoBroad HospitalIgG4-Related Diseases, Lupus Nephritis (LN), Multiple Sclerosis +3
Start: 2026-06-01End: 2031-06-01Target: 75Updated: 2026-05-18